Literature DB >> 31114029

Metastatic melanoma and immunotherapy-related uveitis: an incidence in Northern Ireland.

Michael J Dolaghan1, Bode Oladipo2, Carole A Cooke3, Clara E McAvoy4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31114029      PMCID： PMC7002639          DOI： 10.1038/s41433-019-0473-4

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN： 0950-222X            Impact factor:   3.775


× No keyword cloud information.
  5 in total

1.  Novel therapies for unresectable and metastatic melanoma.

Authors:  Chante Karimkhani; Bobby Y Reddy; Robert P Dellavalle; Srinath Sundararajan
Journal:  BMJ       Date:  2017-11-30

2.  A Rare Case of Pembrolizumab-Induced Uveitis in a Patient with Metastatic Melanoma.

Authors:  Kirollos S Hanna
Journal:  Pharmacotherapy       Date:  2016-10-26       Impact factor: 4.705

3.  Bilateral neuroretinitis and anterior uveitis following ipilimumab treatment for metastatic melanoma.

Authors:  Laura Hahn; Kathryn L Pepple
Journal:  J Ophthalmic Inflamm Infect       Date:  2016-05-10

4.  Ocular toxicity due to Trametinib and Dabrafenib.

Authors:  Stephanie Sarny; Michael Neumayer; Julian Kofler; Yosuf El-Shabrawi
Journal:  BMC Ophthalmol       Date:  2017-08-17       Impact factor: 2.209

5.  Characteristics and management of immunerelated adverse effects associated with ipilimumab, a new immunotherapy for metastatic melanoma.

Authors:  Stephanie Andrews; Rita Holden
Journal:  Cancer Manag Res       Date:  2012-09-12       Impact factor: 3.989
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.